Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Scalp condition healed with prednisone and tacrolimus.

Glucocorticoids can cause long-term loss of body hair by lowering adrenal androgens.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

The combination therapy was effective and well-tolerated, especially in young patients.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Testosterone, DHT, and estradiol significantly affect hair cell growth.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hair hormone levels can indicate obesity-related changes and are useful for research and clinical practice.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Combining methotrexate with low-dose prednisone is more effective for hair regrowth in alopecia areata totalis.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.